Adoptive transfer of costimulated CD4+ T cells induces expansion of peripheral T cells and decreased CCR5 expression in HIV infection-Reference-Cited by-同舟云学术

Adoptive transfer of costimulated CD4+ T cells induces expansion of peripheral T cells and decreased CCR5 expression in HIV infection

Published:2002-01 Issue:1 Volume:8 Page:47-53
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Levine Bruce L.,Bernstein Wendy B.,Aronson Naomi E.,Schlienger Katia,Cotte Julio,Perfetto Steven,Humphries Mary J.,Ratto-Kim Silvia,Birx Deborah L.,Steffens Carolyn,Landay Alan,Carroll Richard G.,June Carl H.

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.nature.com/articles/nm0102-47.pdf

Reference42 articles.

1. Rosenberg, E.S. et al. Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia. Science 278, 1447–1450 (1997).

2. Kalams, S.A. & Walker, B.D. The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses. J. Exp. Med. 188, 2199–2204 (1998).

3. Rosenberg, E.S. et al. Immune control of HIV–1 after early treatment of acute infection. Nature 407, 523–526 (2000).

4. Carcelain, G., Debre, P. & Autran, B. Reconstitution of CD4+ T lymphocytes in HIV-infected individuals following antiretroviral therapy. Curr. Opin. Immunol. 13, 483–488 (2001).

5. Walter, E.A. et al. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N. Engl. J. Med. 333, 1038–1044 (1995).

Cited by 148 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A ENGENHARIA GENÉTICA DA CRISPR/CAS9 NO GENE CCR5 COMO POSSÍVEL FONTE TERAPÊUTICA DO VÍRUS DA IMUNODEFICIÊNCIA HUMANA;REVISTA FOCO;2024-01-22

2. CCR5-edited CD4+ T cells augment HIV-specific immunity to enable post-rebound control of HIV replication;Journal of Clinical Investigation;2021-04-01

3. Infusion of CCR5 Gene-Edited T Cells Allows Immune Reconstitution, HIV Reservoir Decay, and Long-Term Virological Control;2021-03-01

4. Challenges and Opportunities of Using Adoptive T-Cell Therapy as Part of an HIV Cure Strategy;The Journal of Infectious Diseases;2021-02-01

5. The long road to the first FDA-approved gene therapy: chimeric antigen receptor T cells targeting CD19;Cytotherapy;2020-02